Former Express Scripts boss Tim Wentworth takes the reigns as the new CEO at Walgreens at a pivotal juncture. Strong competitors like Walmart are making strides in the pharmacy aisle, while Walgreens pharmacists are protesting what they view as insufficient staffing and resources to do their jobs safely and ethically for their patients. 


Walmart Pharmacy has long been a leader on price, and over the past year it has also become a leader in customer satisfaction with its pharmacy services and speed/checkout. While Walgreens has struggled in these areas versus peers, in recent months customers feel it has improved and is closing the gap with Walmart.


Wentworth will need to cut through the noise and identify what will move the needle most for Walgreens in his first 90 days. While employees feel stores are understaffed, customers sharing feedback with HundredX actually rank Walgreens as a leader in both store and health services, and middle of the pack on speed and checkout. The real issue, according to customers, appears to be its employees’ knowledge and attitude, where it lags its peers.


Analyzing over 70,000 pieces of customer feedback across 12 pharmacy brands, from September 2022 through September 2023, we find:


  • Walgreens’ growth outlook is improving, with a 1% increase in Purchase Intent¹,² over the past three months while most other leading brands were flat to down.
  • Some key reasons for the improvement include progress for Walgreens’ pharmacy services, speed, and checkout recently. Net favorability³ for pharmacy services and speed/checkout were +4% and +2% over the last quarter.
  • Walgreens should continue to lean into its leadership in satisfaction with health and store services. The management team seems to be appropriately focused on this opportunity based on its comments on its October 12 earnings call. The challenge lies in maintaining this lead amidst staffing woes and recent employee walkouts. Its recent unveiling of new virtual healthcare services should help.
  • Meanwhile, after improvements over the year, Walmart is now the leader in customer satisfaction with pharmacy services, passing Kroger and Costco.
  • In the digital arena, Walgreens and Walmart exhibit closely matched customer perception concerning website and app usability. With a 1% rise in Purchase Intent for customers who primarily shop online since May, the emphasis on digital platforms makes sense. Wentworth’s experience with digital pharmacies should be useful here. 
  • Slide title

    Write your caption here
    Button
  • Slide title

    Purchase Intent for the pharmacy industry remained stable over the past six months, even as it fell for most other similar industries. Still, Purchase Intent is down slightly

    (-1%) for the pharmacy industry over the past year.

    Button
  • Slide title

    Walmart Pharmacy is the only major pharmacy brand to gain in Purchase Intent (+2%) over the

    past year. It overtook both CVS (-2%) and Walgreens (-1%) while narrowing its gap with Costco

    Pharmacy. Still, Walgreens is starting to make up some ground, gaining 1% over the past three

    months.

    Button
  • Slide title

    While Walmart is the leader in net favorability for pharmacy services, Walgreens has gained 4% in the last three months to narrow its gap with Walmart (-1%).

    Button
  • Slide title

    Walmart Pharmacy is also strong in speed/checkout, having gained 4% net favorability (more than any competitor) in the past year. Walgreens is gaining, however, after jumping 2% in the past three months. Meanwhile, Walmart fell 1%.

    Button
  • Slide title

    Walgreens, not Walmart, is a leader in health services, just behind CVS. Net favorability

    toward health services rose 1% for Walgreens over the past three months. Conversely, Walmart is middle of the pack after falling 3% over the past three months.

    Button
  • Slide title

    Walgreens is also the leader in store services. Net favorability toward store services rose 1% over the past three months while Walmart is at the bottom of the pack after falling 4% over the past three months.

    Button
  • Slide title

    Customers perceive the attitude and knowledge of employees at Walgreens and CVS to be below that of other pharmacies. Meanwhile, with a 1% gain over the year, Walmart is steadily closing the gap with top-ranked

    companies Costco and Kroger.

    Button
  • Slide title

    Purchase Intent for customers who primarily shop in-store fell 2% over the past year and 1%

    over the past six months. While Purchase Intent is also down for people who primarily shop

    online over the year, it has gained 1% since May.

    Button
  • Slide title

    Walmart and Walgreens lead on customer perception toward their websites and apps. However, while Walgreens has gained net favorability in the past three months (+2%), Walmart fell (-4%).

    Button

Please contact our team for a deeper look at HundredX's pharmacy data, which includes more than 150,000 pieces of customer feedback across 12 pharmacy brands (including over 12,000 on Walmart Pharmacy and over 55,000 on Walgreens).


  1. All metrics presented, including Net Purchase (Purchase Intent) and Net Positive Percent / Favorability, are presented on a trailing three-month basis unless otherwise noted.
  2. Purchase Intent represents the percentage of customers who expect to spend more with that chain over the next 12 months, minus those that intend to spend less. We find businesses that see Purchase Intent trends gain versus the industry or peers have often seen revenue growth rates, margins, and/or market share also improve versus peers.
  3. HundredX measures Net Favorability towards a driver of customer satisfaction as Net Positive Percent (NPP), which is the percentage of customers who view a factor as a positive (reason they liked the products, people, or experiences) minus the percentage who see the same factor as a negative.

Strategy Made Smarter


HundredX works with a variety of companies and their investors to answer some of the most important strategy questions in business:

  • Where are customers "migrating"?
  • What are they saying they will use more of in the next 12 months?
  • What are the key drivers of their purchase decisions and financial outcomes?


Current clients see immediate benefits across multiple areas including strategy, finance, operations, pricing, investing, and marketing.


Our insights enable business leaders to define and identify specific drivers and decisions enabling them to grow their market share.


Please contact our team to learn more about which businesses across 75 industries are best positioned with customers and the decisions you can make to grow your brand’s market share.

####


HundredX is a mission-based data and insights provider. HundredX does not make investment recommendations. However, we believe in the wisdom of the crowd to inform the outlook for businesses and industries. For more info on specific drivers of customer satisfaction, other companies within 75+ other industries we cover, or if you'd like to learn more about using Data for Good, please reach out: https://hundredx.com/contact.

Share This Article

06 May, 2024
Sure, lattes, mochaccinos, and cappuccinos are pricey, but they taste delicious. For many consumers, the great taste of coffee shop coffee made it worth the cost. But customers at Starbucks aren't so sure the tradeoff is worth it anymore. Examining more than 420,000 pieces of feedback across the Quick, Fast, Casual (QFC) industry, including over 21,000 on Starbucks, we find: Starbuck's Purchase Intent 1,2 is down 3% over the past six months, with most of that dip occurring over the past few months. By contrast, Dunkin' Donuts has remained within a tight range over the past six months, as did an average of other, smaller coffee chains. Customers increasingly see less value in Starbucks. Starbuck's Value perception 3 fell 5% over the past six months, compared to just 1% for Dunkin' Donuts. However, it also fell 5% for the average of the smaller coffee chains. Coffee drinkers feel significantly unhappier about Starbuck's quality and taste. Starbuck's Taste perception fell 4% over the past six months, while rising 1% for competitors. Likewise, its Quality perception dipped 3% over the same time period (and 8% over the year). Ultimately, Starbuck's perceived drop in taste is leading inflation-weary consumers to say they plan to spend less at the coffee chain, as the value just isn't as good.
06 May, 2024
Forbes Best Brands for Social Impact, Powered by HundredX
06 May, 2024
Ozempic once dominated the headlines, but GLP-1 competitor Mounjaro is winning over customers. GLP-1 drugs, used for treating diabetes and aiding in weight loss, are relatively new on the market yet have surged in popularity over the last year. They're becoming so popular that J.P. Morgan estimates that 30 million people in the US may be using a GLP-1 drug by 2030. This statistic presents a significant potential for early drug creator Novo Nordisk (Ozempic, Wegovy), and perhaps an even bigger one for Eli Lilly (Mounjaro, Zepbound). HundredX data indicates Eli Lilly is in a position to win over Novo Nordisk as Mounjaro's Usage Intent widens against the competition. Ozempic may have name recognition, but customers feel more positively about Mounjaro's effectiveness and lifestyle impact, even if they aren't excited about its high price. Examining 1,500 pieces of customer feedback across Mounjaro, Ozempic, and Wegovy, we find: GLP-1 users increasingly say they plan to use Mounjaro more, and Ozempic less . Mounjaro’s Usage Intent is up 19% since July, Wegovy’s is up 3%, and Ozempic has stayed within a tight range. Customers feel Mounjaro is more effective than competing drugs, but it’s harder to get . Mounjaro outperforms other GLP-1 drugs in effectiveness, lifestyle impact, and side effects. However, customers dislike its cost and availably more than competitors.
Share by: